Testing effectiveness (Phase 2)Study completedNCT02236195
What this trial is testing
Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes
Who this might be right for
Urothelial Carcinoma
Mirati Therapeutics Inc. 17